CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation.

AIM To investigate the role of nuclear translocation of calcyclin binding protein, also called Siah-1 interacting protein (CacyBP/SIP), in gastric carcinogenesis. METHODS The expression of CacyBP/SIP protein in gastric cancer cell lines was detected by Western blot. Immunofluorescence experiments were performed on gastric cancer cell lines that had been either unstimulated or stimulated with gastrin. To confirm the immunofluorescence findings, the relative abundance of CacyBP/SIP in nuclear and cytoplasmic compartments was assessed by Western blot. The effect of nuclear translocation of CacyBP/SIP on cell proliferation was examined using MTT assay. The colony formation assay was used to measure clonogenic cell survival. The effect of CacyBP/SIP nuclear translocation on cell cycle progression was investigated. Two CacyBP/SIP-specific siRNA vectors were designed and constructed to inhibit CacyBP/SIP expression in order to reduce the nuclear translocation of CacyBP/SIP, and the expression of CacyBP/SIP in stably transfected cells was determined by Western blot. The effect of inhibiting CacyBP/SIP nuclear translocation on cell proliferation was then assessed. RESULTS CacyBP/SIP protein was present in most of gastric cancer cell lines. In unstimulated cells, CacyBP/SIP was distributed throughout the cytoplasm; while in stimulated cells, CacyBP/SIP was found mainly in the perinuclear region. CacyBP/SIP nuclear translocation generated a growth-stimulatory effect on cells. The number of colonies in the CacyBP/SIP nuclear translocation group was significantly higher than that in the control group. The percentage of stimulated cells in G1 phase was significantly lower than that of control cells (69.70% ± 0.46% and 65.80% ± 0.60%, control cells and gastrin-treated SGC7901 cells, P = 0.008; 72.99% ± 0.46% and 69.36% ± 0.51%, control cells and gastrin-treated MKN45 cells, P = 0.022). CacyBP/SIPsi1 effectively down-regulated the expression of CacyBP/SIP, and cells stably transfected by CacyBP/SIPsi1 were then chosen for further cellular assays. In CacyBP/SIPsi1 stably transfected cells, CacyBP/SIP was shown to be distributed throughout the cytoplasm, irregardless of whether they were stimulated or not. After CacyBP/SIP nuclear translocation was reduced, there had no major effect on cell proliferation, as shown by MTT assay. There had no enhanced anchorage-dependent growth upon stimulation, as indicated by colony formation in flat plates. No changes appeared in the percentage of cells in G0-G1 phase in either cell line (71.09% ± 0.16% and 70.86% ± 0.25%, control cells and gastrin-treated SGC7901-CacyBP/SIPsi1 cells, P = 0.101; 74.17% ± 1.04% and 73.07% ± 1.00%, control cells and gastrin-treated MKN45-CacyBP/SIPsi1 cells, P = 0.225). CONCLUSION CacyBP/SIP nuclear translocation promotes the proliferation and cell cycle progression of gastric cancer cells.

[1]  Zhai Hui-hong.  Effects of epidermal growth factor on the nuclear translocation of CacyBP/SIP in colon cancer cells transfected by over expressed lentivirus vector of CacyBP/SIP , 2012 .

[2]  Zhai Hui-hong.  Effect of CoCl_2 on CacyBP/SIP nuclear translocation of colon carcinoma cell lines , 2012 .

[3]  Xiaohua Li,et al.  CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells , 2011, Molecular carcinogenesis.

[4]  D. Bowtell,et al.  Siah1/SIP regulates p27kip1 stability and cell migration under metabolic stress , 2011, Cell cycle.

[5]  Q. Ma,et al.  CacyBP/SIP Expression is Involved in the Clinical Progression of Breast Cancer , 2010, World Journal of Surgery.

[6]  X. Wang,et al.  Expression and Clinical Significance of CacyBP/SIP in Pancreatic Cancer , 2008, Pancreatology.

[7]  Haifeng Jin,et al.  Expression of Calcyclin-binding Protein/Siah-1 Interacting Protein in Normal and Malignant Human Tissues: An Immunohistochemical Survey , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  D. Fan,et al.  Expression and nucleus translocation of calcyclin binding protein in colon cancer cells , 2008 .

[9]  Liu Hong,et al.  Calcyclin-Binding Protein Inhibits Proliferation, Tumorigenicity, and Invasion of Gastric Cancer , 2007, Molecular Cancer Research.

[10]  Haifeng Jin,et al.  Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[11]  Kaichun Wu,et al.  Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. , 2007, Biochemical and biophysical research communications.

[12]  D. Fan,et al.  Establishment and characterization of calcyclin binding protein (CacyBP) monoclonal antibody. , 2006, Hybridoma.

[13]  John Calvin Reed,et al.  Critical function for SIP, a ubiquitin E3 ligase component of the beta-catenin degradation pathway, for thymocyte development and G1 checkpoint. , 2006, Immunity.

[14]  D. Fan,et al.  Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP) , 2004, Gastric Cancer.

[15]  Jing Wu,et al.  Translocation and phosphorylation of calcyclin binding protein during retinoic acid-induced neuronal differentiation of neuroblastoma SH-SY5Y cells. , 2003, Journal of biochemistry and molecular biology.

[16]  J. Kuźnicki,et al.  Ca2+-dependent Translocation of the Calcyclin-binding Protein in Neurons and Neuroblastoma NB-2a Cells* , 2002, The Journal of Biological Chemistry.

[17]  J. Kuźnicki,et al.  Ca 2-dependent Translocation of the Calcyclin-binding Protein in Neurons and Neuroblastoma NB2 a Cells * , 2002 .

[18]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[19]  J. Kuźnicki,et al.  Molecular Cloning and Expression of a Mouse Brain cDNA Encoding a Novel Protein Target of Calcyclin , 1998, Journal of neurochemistry.

[20]  L. Pradayrol,et al.  Coupling of pancreatic gastrin/cholecystokinin-B (G/CCKB) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells , 1994, Regulatory Peptides.

[21]  L. Pradayrol,et al.  Inhibition of gastrin‐induced proliferation of AR4–2j cells by calcium channel antagonists , 1994, International journal of cancer.